Intra-Cellular Therapies

Summary

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

History

Intra-Cellular Therapies, Inc. (ICT) was founded in 2003 by Dr. Paul Greengard with a team of leading scientific researchers from Rockefeller University, targeting diseases of the central nervous system (CNS). The company is focused on transforming the lives of patients to whom existing therapies for cognition and movement disorders have had limited impact. In the years since, ICT has established a sustained portfolio of clinical and preclinical programs directed at a number of CNS indications, encompassing psychiatry, neurology and orphan diseases.

Mission

At Intra-Cellular Therapies, our mission is to develop transformational treatments that make a meaningful difference in the lives of people affected by diseases and disorders of the central nervous system. We believe we can make profound improvements in the lives of patients with such diseases and disorders.

Vision

Our vision is to become a leading player in the global neuroscience space and make a positive impact on the lives of those affected by CNS diseases and disorders.

References

https://in.investing.com/equities/intracellular-th

https://finance.yahoo.com/quote/ITCI/profile?p=ITCI

https://www.crunchbase.com/organization/intra-cellular-therapies#:~:text=Intra%2DCellular%20Therapies%20(ITI),Central%20Nervous%20System%20(CNS).&text=expertise%20into%20novel%20drugs.

https://sec.report/CIK/0001567514

https://companiesmarketcap.com/

https://www.intracellulartherapies.com

Contacts

Follow Us

Intra-Cellular Therapies

Share

Contacts

Follow Us